Savant Capital LLC Takes $283,000 Position in Axcelis Technologies, Inc. $ACLS

Savant Capital LLC purchased a new stake in Axcelis Technologies, Inc. (NASDAQ:ACLS) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 4,064 shares of the semiconductor company’s stock, valued at approximately $283,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in ACLS. MassMutual Private Wealth & Trust FSB increased its position in Axcelis Technologies by 50.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 481 shares of the semiconductor company’s stock valued at $34,000 after acquiring an additional 161 shares in the last quarter. Parallel Advisors LLC lifted its holdings in Axcelis Technologies by 129.0% during the 2nd quarter. Parallel Advisors LLC now owns 545 shares of the semiconductor company’s stock worth $38,000 after buying an additional 307 shares in the last quarter. Bayforest Capital Ltd bought a new position in Axcelis Technologies in the 1st quarter valued at $38,000. Signaturefd LLC increased its stake in shares of Axcelis Technologies by 255.5% in the 1st quarter. Signaturefd LLC now owns 1,294 shares of the semiconductor company’s stock valued at $64,000 after buying an additional 930 shares during the period. Finally, Caitong International Asset Management Co. Ltd increased its stake in shares of Axcelis Technologies by 100.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,352 shares of the semiconductor company’s stock valued at $67,000 after buying an additional 677 shares during the period. Institutional investors and hedge funds own 89.98% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on ACLS. Zacks Research raised Axcelis Technologies from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 6th. DA Davidson upped their target price on shares of Axcelis Technologies from $90.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, October 2nd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axcelis Technologies in a research note on Monday. Wall Street Zen upgraded shares of Axcelis Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, November 2nd. Finally, Benchmark raised shares of Axcelis Technologies from a “hold” rating to a “buy” rating and set a $105.00 price target for the company in a research note on Thursday, October 2nd. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $98.80.

Axcelis Technologies Price Performance

Shares of ACLS opened at $77.70 on Wednesday. The stock has a market cap of $2.41 billion, a P/E ratio of 15.89 and a beta of 1.75. Axcelis Technologies, Inc. has a 1 year low of $40.40 and a 1 year high of $102.93. The stock’s 50-day moving average price is $86.64 and its two-hundred day moving average price is $76.17. The company has a current ratio of 6.01, a quick ratio of 4.26 and a debt-to-equity ratio of 0.04.

Axcelis Technologies (NASDAQ:ACLS) last announced its quarterly earnings results on Monday, April 21st. The semiconductor company reported $1.71 EPS for the quarter. Axcelis Technologies had a return on equity of 16.26% and a net margin of 17.69%.The company had revenue of $252.42 million during the quarter. On average, equities analysts predict that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current year.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.